The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap - Anneliene H. Jonker; Elena-Alexandra Tataru; Holm Graessner; David Dimmock; Adam Jaffe; Gareth Baynam; James Davies; Shruti Mitkus; Oxana Iliach; Rich Horgan; Erika F. Augustine; Alison Bateman-House; et al. (Nature Reviews Drug Discovery, 2025)